menu
    • menu

    Company profile for AgeX Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. We are building upon the foundation of our proprietary technologies such as PureStem® and induced Tissue Regeneration (iTR™) to develop innovative medicines designed to address some of the largest unsolved problems in aging. Through PureStem® we have the ability to generate pluripotent stem cell-derived young ...
    AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. We are building upon the foundation of our proprietary technologies such as PureStem® and induced Tissue Regeneration (iTR™) to develop innovative medicines designed to address some of the largest unsolved problems in aging. Through PureStem® we have the ability to generate pluripotent stem cell-derived young cells of any type for potential application in a range of degenerative diseases of aging with a high unmet medical need. iTR™ is our revolutionary longevity platform aiming to unlock cellular immortality.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AgeX TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    965 Atlantic Avenue Suite 101 Alameda, CA 94501
    Telephone
    Telephone
    +1 (510) 671-8370
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.agexinc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/agexthera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
    Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics

    26 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/26/2852790/0/en/Serina-Therapeutics-Announces-Completion-of-Merger-with-AgeX-Therapeutics.html

    GLOBENEWSWIRE
    26 Mar 2024
    Share Share
    AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results
    AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results

    22 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/22/2851162/0/en/AgeX-Therapeutics-Reports-Fourth-Quarter-and-Annual-2023-Financial-Results.html

    GLOBENEWSWIRE
    22 Mar 2024
    Share Share
    AgeX Therapeutics Reports Third Quarter 2023 Financial Results
    AgeX Therapeutics Reports Third Quarter 2023 Financial Results

    14 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231114746069/en

    BUSINESSWIRE
    14 Nov 2023
    Share Share
    AgeX keeps defying time to survive multiyear cash crunch
    AgeX keeps defying time to survive multiyear cash crunch

    15 Aug 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/agex-keeps-defying-time-coming-through-another-quarter-despite-multi-year-cash-crunch

    Nick Paul Taylor FIERCE BIOTECH
    15 Aug 2023
    Share Share
    AgeX Therapeutics Reports Second Quarter 2023 Financial Results
    AgeX Therapeutics Reports Second Quarter 2023 Financial Results

    14 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230814318651/en

    BUSINESSWIRE
    14 Aug 2023
    Share Share
    AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock
    AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock

    24 Jul 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230724163190/en

    BUSINESSWIRE
    24 Jul 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search